MétaCan
Menu
Back to cohort
Record W2623521763 · doi:10.1212/wnl.0000000000004058

Diagnosis and management of dementia with Lewy bodies

2017· review· en· W2623521763 on OpenAlexfundno aff
Ian G. McKeith, Bradley F. Boeve, Dennis W. Dickson, Glenda M. Halliday, John‐Paul Taylor, Daniel Weintraub, Dag Aarsland, James E. Galvin, Johannes Attems, Clive Ballard, Ashley Bayston, Thomas G. Beach, ‪Frederic Blanc‬, Nicolaas I. Bohnen, Laura Bonanni, José Brás, Patrik Brundin, David J. Burn, Alice Chen‐Plotkin, John E. Duda, Omar M. A. El‐Agnaf, Howard Feldman, Tanis J. Ferman, Dominic ffytche, Hiroshige Fujishiro, Douglas Galasko, Jennifer G. Goldman, Stephen N. Gomperts, Neill R. Graff‐Radford, Lawrence S. Honig, Álex Iranzo, Kejal Kantarci, Daniel Kaufer, Walter A. Kukull, Virginia M.‐Y. Lee, James B. Leverenz, Simon J.G. Lewis, Carol F. Lippa, Angela Lunde, Mario Masellis, Eliezer Masliah, Pamela J. McLean, Brit Mollenhauer, Thomas J. Montine, Emilio Moreno, Etsuro Mori, Melissa E. Murray, John T. O’Brien, Sotoshi Orimo, Ronald B. Postuma, Shankar Ramaswamy, Owen A. Ross, David P. Salmon, Andrew Singleton, Angela Taylor, Alan Thomas, Pietro Tiraboschi, Jon B. Toledo, John Q. Trojanowski, Debby W. Tsuang, Zuzana Walker, Masahito Yamada, Kenji Kosaka

Bibliographic record

VenueNeurology · 2017
Typereview
Languageen
FieldMedicine
TopicParkinson's Disease Mechanisms and Treatments
Canadian institutionsnot available
FundersNational Institute of Neurological Disorders and StrokeNational Institute for Dementia ResearchNational Institute on AgingNIHR Newcastle Biomedical Research CentreProgramme Grants for Applied ResearchNational Health and Medical Research CouncilMedical Research CouncilCanadian Institutes of Health ResearchQatar Biomedical Research Institute, Hamad Bin Khalifa UniversityHouston Methodist Research InstituteAvid RadiopharmaceuticalsPerelman School of Medicine, University of PennsylvaniaGenentechUniversité de StrasbourgH. Lundbeck A/SU.S. Department of Health and Human ServicesTauRx PharmaceuticalsNewcastle upon Tyne Hospitals NHS Foundation TrustEisaiMinistero della SaluteUniversity College LondonCentre National de la Recherche ScientifiqueKing's College LondonUniversity of ExeterNational Institute for Health and Care ResearchUniversity of OxfordACADIA PharmaceuticalsFondation Brain CanadaPfizerUniversity of WashingtonTeva Pharmaceutical IndustriesBristol-Myers SquibbCleveland ClinicCurePSPMassachusetts General HospitalLittle Family FoundationU.S. Department of Veterans AffairsUniversity of PennsylvaniaAlzheimer's Drug Discovery FoundationNational Institutes of HealthKanazawa UniversityDemensförbundetFlorida Department of HealthThomas Jefferson UniversityCHDI FoundationInternational Parkinson and Movement Disorder SocietyBiogenRush UniversityUniversity of TorontoUniversity of North Carolina at Chapel HillVan Andel Research InstituteUniversidad del AtlánticoUniversity of California, San DiegoHouston Methodist HospitalMinistero dello Sviluppo EconomicoNewcastle UniversityHeart and Stroke Foundation of CanadaSanofiWeston Brain InstituteCalifornia Institute for Regenerative MedicineFlorida Atlantic UniversityEli Lilly and Company
KeywordsDementia with Lewy bodiesNeurocognitiveREM sleep behavior disorderMedicineClinical trialNeuroimagingDementiaDiseaseLewy bodyPsychiatryIntensive care medicinePsychologyParkinson's diseaseNeurosciencePathologyCognition

Abstract

fetched live from OpenAlex

The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for the last decade. The revised DLB consensus criteria now distinguish clearly between clinical features and diagnostic biomarkers, and give guidance about optimal methods to establish and interpret these. Substantial new information has been incorporated about previously reported aspects of DLB, with increased diagnostic weighting given to REM sleep behavior disorder and <sup>123</sup>iodine-metaiodobenzylguanidine (MIBG) myocardial scintigraphy. The diagnostic role of other neuroimaging, electrophysiologic, and laboratory investigations is also described. Minor modifications to pathologic methods and criteria are recommended to take account of Alzheimer disease neuropathologic change, to add previously omitted Lewy-related pathology categories, and to include assessments for substantia nigra neuronal loss. Recommendations about clinical management are largely based upon expert opinion since randomized controlled trials in DLB are few. Substantial progress has been made since the previous report in the detection and recognition of DLB as a common and important clinical disorder. During that period it has been incorporated into DSM-5, as major neurocognitive disorder with Lewy bodies. There remains a pressing need to understand the underlying neurobiology and pathophysiology of DLB, to develop and deliver clinical trials with both symptomatic and disease-modifying agents, and to help patients and carers worldwide to inform themselves about the disease, its prognosis, best available treatments, ongoing research, and how to get adequate support.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.003
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.005
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.001
Science and technology studies0.0020.001
Scholarly communication0.0010.001
Open science0.0010.002
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.077
GPT teacher head0.347
Teacher spread0.270 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4,446
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueNeurologySame topicParkinson's Disease Mechanisms and TreatmentsFrench-language works237,207